JOINT MEDIA RELEASE
Wits RHI, Shandukani Research Centre - 14 February 2020
Wits RHI Shandukani Research Centre is pleased to inform the public and all relevant stakeholders that the site has successfully enrolled its first participant into MTN 042, or DELIVER, a Phase 3b safety study of the monthly dapivirine vaginal ring and Truvada as daily oral pre-exposure prophylaxis (PrEP) in pregnant women.
This study, which is being conducted by the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN) is also designed to assess adherence to and acceptability of these two HIV prevention tools. Wits RHI Shandukani Research Centre is one of four sites in southern Africa conducting the DELIVER study and was the first to enroll and screen participants. The study will complement an ongoing NIH-funded IMPAACT trial of PrEP in adolescents and young women during pregnancy and the first six months after birth.
After going through all the required screening and enrollment procedures the participant was successfully randomized on Tuesday 11 February 2020. This enrolment is a cause for celebration and marks a huge milestone for the research site
Women need reliable HIV prevention methods that they know are safe during pregnancy for themselves and their babies,” said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, in a NIAID press release about the start of the study. “This new clinical trial will provide important data on the safety of PrEP and the dapivirine ring during pregnancy and will help expectant parents make well-informed HIV prevention choices.”
Wits RHI Shandukani Research Centre has conducted numerous studies in Maternal and Child Health since moving from Chris Hani Baragwanath Hospital in 2012, to the inner city. Prior to that the Research site conducted research mainly in children and adolescents since 2003. The site is situated on the 2nd (Top) floor of the Shandukani building, Hillbrow Health Precinct. On the ground floor is the Midwife Obstetric Unit. Wits RHI Shandukani Research Centre (SRC) is a research unit consisting of a technically diverse team of highly experienced staff who have managed a variety of clinical research studies over the last 17 years
For additional information please contact the Principal Investigator for MTN-042 study at the below contact address.
Dr Lee Fairlie
Telephone Number: +27 11 358 5317
Cell No. +27 82 780 9997